10
Dec
2024

Wanbang Biopharmaceuticals

Exhibitor at CPHI Middle East 2024 stand 4.F28
About Us

Wanbang Biopharmaceuticals is a global innovation-driven pharmaceutical company in China, and is a core member enterprise of Fosun Pharma. Business covers the whole healthcare industry chain including pharmaceutical R&D, manufacturing, wholesale and distribution. Several production lines have passed FDA /EU site audits.  Key products include Human Insulins and GLP-1 products, EPO, and Heparin Sodium, OSD products such as Ticagrelor Tabs, Tofacitinib Tabs, Crizotinib Caps and Osimertinib Tabs.  APIs includes Insulins, Heparin Sodium, Venetoclax and Febuxostat

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Middle East 2024
  • 10 Dec 2024 - 12 Dec 2024
  • Riyadh Front Exhibition & Convention Center Riyadh, Saudi Arabia
  • Visit us at stand 4.F28

Products Featured at CPHI Middle East 2024